C4E-90831-30591
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-25
Dose 1 — Pfizer-BioNTech
-
2021-01-05
Registered in v-safe
- 2021-01-05
- 2021-01-08
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
-
2021-04-15
Survey response — 3 months, dose 2MedDRA: Gestational hypertension, Pre-eclampsia — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Gestational hypertension/pre eclampsiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Report sent to call center — 3 months, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-27
-
2021-07-15
Survey response — 6 months, dose 2MedDRA: Haemorrhage, Hypertension, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Pre eclampsia, postpartum hemorrhage, ongoing high blood pressureMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-15
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-21
- 2021-07-24
-
2022-01-16
Survey response — 12 months, dose 2MedDRA: Arthritis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Auto immune inflammatory arthritisMedDRA releases: 2024-11 · check-in free text available
-
2022-01-16
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-25 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
Free text
Release 7 — 3 months, dose 2
Symptoms: Gestational hypertension/pre eclampsia
Release 9 — 6 months, dose 2
Symptoms: Pre eclampsia, postpartum hemorrhage, ongoing high blood pressure
Release 10 — 12 months, dose 2
Symptoms: Auto immune inflammatory arthritis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthritis | · | · | ✓ |
| SD | Gestational hypertension | ✓ | ✓ | ✓ |
| SD | Haemorrhage | ✓ | · | ✓ |
| SD | Hypertension | ✓ | · | ✓ |
| SD | Pre-eclampsia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release